SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model

Схожие документы

• SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
  по: Madireddi, Shravan, et al.
  Опубликовано: (2012)
• Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
  по: Madireddi, Shravan, et al.
  Опубликовано: (2012)
• SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer
  по: Srivastava, Abhishek K., et al.
  Опубликовано: (2015)
• ProtEx™ technology for the generation of novel therapeutic cancer vaccines
  по: Schabowsky, Rich-Henry, et al.
  Опубликовано: (2009)
• A Novel Form of 4-1BBL Has Better Immunomodulatory Activity than an Agonistic Anti-4-1BB Ab without Ab Associated Severe Toxicity
  по: Schabowsky, Rich-Henry, et al.
  Опубликовано: (2009)